Tibor Csőszi
Tibor Csőszi publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.
- World rank
- #139,456 of 1,633,909 ranked researchers
- Rank in United States
- #59,017 of 358,040
- Works
- 30
- Citations
- 176
- Citations per work
- 5.9
What does Tibor Csőszi research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Oncology46% of their works
- 2Pulmonary and Respiratory Medicine27% of their works
- 3Cancer Research6% of their works
- 4Surgery6% of their works
- 5Molecular Biology4% of their works
- 6Genetics2% of their works
Research topics
Which keywords describe Tibor Csőszi's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Breast Cancer, Metastatic Breast Cancer, Targeted Therapy, Chemotherapy, Clinical Trials and Metastatic.
- Treatment
- Renal Cell Carcinoma
- Genomic Profiles
- Trastuzumab
- Prognostic Factors
- Immunotherapy
- EGFR Mutations
- CDK4/6 Inhibitors
- Metastatic
- Chemotherapy
- Metastatic Breast Cancer
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Breast Cancer
- Targeted Therapy
- Clinical Trials
- ALK Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- HER2
- Palbociclib
- Taxanes
- Cancer Genomics
- Mutational Signatures
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Immune Checkpoint Blockade91 topic
- PD-1 and PD-L191 topic
- Breast Cancer82 topics
- Metastatic Breast Cancer82 topics
- Targeted Therapy83 topics
- Chemotherapy62 topics
- Clinical Trials62 topics
- Metastatic62 topics
- ALK Inhibitors41 topic
- CDK4/6 Inhibitors41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- EGFR Mutations41 topic
- HER241 topic
- Immunotherapy42 topics
- Palbociclib41 topic
- Prognostic Factors42 topics
- Taxanes41 topic
- Trastuzumab41 topic
- Cancer Genomics21 topic
- Genomic Profiles21 topic
- Mutational Signatures21 topic
- Renal Cell Carcinoma21 topic
- Small-Cell Lung Cancer21 topic
- Treatment21 topic
Where does Tibor Csőszi work?
Tibor Csőszi's main affiliation in the publication record is Merck & Co., Inc., Rahway, NJ, USA (United States), United States.
How many publications and citations does Tibor Csőszi have?
Science Explorer counts 30 works and 176 citations for Tibor Csőszi, ranking #139,456 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.